Tsunemasa Watanabe

11PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)HaematologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 08, 2026
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions.

|May 04, 2026
Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score-Matched Study Using Linear Mixed-Effects Models.

|Mar 04, 2026
Characteristic Hepatic Atrophy in Abemaciclib-Induced Liver Injury: A Comparative Review of Three Cases.

Yuwa Ando, Tsunamasa Watanabe, Tatsuya Suzuki

|Feb 22, 2026
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Fanpu Ji, Sally Tran, Hidenori Toyoda

|Feb 07, 2026
Prognostic Value of an Early Response to Tolvaptan and Its Clinical Implications in Patients With Cirrhosis and Hepatic Edema: A Nationwide Multicenter Cohort Study.

Kaori Koyano, Taeang Arai, Hidenori Toyoda

|Mar 13, 2024
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.

Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun

Pageof 2

Frequent Collaborators

6 joint publications

Toru Ishikawa

6 joint publications

Hidenori Toyoda

6 joint publications

Masanori Atsukawa

4 joint publications

Haruki Uojima